These innovative treatments, Tirzepatide , represent a significant advancement in managing metabolic dysfunction and potentially related disorders. They are grouped as GLP-1 hormone activators , meaning these substances to replicate the endogenous GLP-1 substance , boosting metabolic production and reducing appetite . Although Tirzepatide each one